RxDoctor Payments Data

Adam Luchey, MD

Urology · Tampa, FLNPI 1174785794

Payments from drug & device makers

What this record shows

16 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 56.2% of the total. 2025 is the largest year on record at $4,389, more than ten times the $243 reported in 2019.

$7,166in general payments, 2019–2025

Across 50 payments — averaging $143.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals Inc.$4K
  • Boston Scientific$2K
  • Axonics, Inc.$218
  • Baxter Healthcare$209
  • Davol Inc.$122
  • Penumbra, Inc.$116
  • plus $740 from 10 others
$69,578in research payments, 2019–2025

Across 15 payments — averaging $4638.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$32K
  • Pfizer$19K
  • QED Therapeutics, Inc.$18K

What the payments were for

  • Speaking & faculty fees$3,80053%
  • Food & beverage$3,36647%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,166 in reported general payments places this provider in the 65th percentile of 935 urology providers in Florida.

See all urology providers in Florida →

Medicare billing

Part B allowed, 2024
$44,902
Medicare patients
120
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →